PMID: 9449720Mar 21, 1998Paper

The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS

The Journal of Experimental Medicine
L ContiS Gessani

Abstract

Although apoptosis is considered one of the major mechanisms of CD4(+) T cell depletion in HIV-infected patients, the virus-infected cells somehow appear to be protected from apoptosis, which generally occurs in bystander cells. Vpr is an auxiliary HIV-1 protein, which, unlike the other regulatory gene products, is present at high copy number in virus particles. We established stable transfectants of CD4+ T Jurkat cells constitutively expressing low levels of vpr. These clones exhibited cell cycle characteristics similar to those of control-transfected cells. Treatment of control clones with apoptotic stimuli (i.e., cycloheximide/tumor necrosis factor alpha (TNF-alpha), anti-Fas antibody, or serum starvation) resulted in a massive cell death by apoptosis. In contrast, all the vpr-expressing clones showed an impressive protection from apoptosis independently of the inducer. Notably, vpr antisense phosphorothioate oligodeoxynucleotides render vpr-expressing cells as susceptible to apoptosis induced by cycloheximide and TNF-alpha as the control clones. Moreover, the constitutive expression of HIV-1 vpr resulted in the upregulation of bcl-2, an oncogene endowed with antiapoptotic activities, and in the downmodulation of bax, a proa...Continue Reading

References

Jul 10, 1992·Science·L MeyaardF Miedema
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·L RaoE White
Jun 1, 1992·Trends in Pharmacological Sciences·W BurschR Schulte-Hermann
Apr 15, 1991·Annals of Internal Medicine·A S FauciG Pantaleo
Nov 1, 1990·Immunology Today·J A HabeshawF Manca
Jun 1, 1990·Journal of Virology·E A CohenW A Haseltine
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N HattoriG Franchini
Dec 1, 1995·Journal of Virology·H ZhuT Shenk
Apr 1, 1995·AIDS Research and Human Retroviruses·S F PurvisM M Lederman
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·B NardelliF T Valentine
Feb 1, 1995·Current Opinion in Genetics & Development·Y Shen, T E Shenk
Dec 1, 1993·Genes & Development·E White
Oct 21, 1994·Cell·Z N Oltvai, S J Korsmeyer
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·N K HeinzingerM Emerman
Jun 1, 1993·AIDS Research and Human Retroviruses·M L GougeonL Montagnier
May 1, 1994·The Journal of Experimental Medicine·P Di MarzioS Gessani
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·S A McCarthyT Van Dyke
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·S HendersonA Rickinson
Apr 1, 1993·Journal of Virology·N E CrookL K Miller
Mar 1, 1993·AIDS Research and Human Retroviruses·M L GougeonL Montagnier
Feb 1, 1996·Molecular Aspects of Medicine·D J McConkeyS Orrenius
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·R Leopardi, B Roizman
Sep 1, 1996·Cytometry·Z DarzynkiewiczF Traganos

❮ Previous
Next ❯

Citations

Jan 1, 2013·Cellular and Molecular Life Sciences : CMLS·Nathan W Cummins, Andrew D Badley
Dec 21, 2004·Springer Seminars in Immunopathology·Marie Larsson
May 6, 2003·Biochemical and Biophysical Research Communications·Damien ArnoultJérôme Estaquier
Oct 24, 1998·Immunology Today·E MeinlB Fleckenstein
Oct 6, 1999·Current Opinion in Biotechnology·M Federico
Sep 1, 2000·Microbes and Infection·T FukumoriA Adachi
Apr 28, 2001·Cytokine & Growth Factor Reviews·H Everett, G McFadden
Jan 1, 2010·Cell Death & Disease·N W Cummins, A D Badley
Jul 13, 2013·Cell Death & Disease·A D BadleyS R Lewin
Nov 24, 1999·European Journal of Biochemistry·K Wecker, B P Roques
Apr 2, 1999·Immunology and Cell Biology·A Jaworowski, S M Crowe
Feb 22, 2001·The Journal of Experimental Medicine·G Basañez, J Zimmerberg
May 15, 2004·DNA and Cell Biology·Parithosh K TungaturthiAlagarsamy Srinivasan
Sep 6, 2000·Proceedings. Biological Sciences·R A ArnaoutD Wodarz
Mar 1, 1995·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·F Belardelli
Feb 24, 2005·Retrovirology·Erwann Le Rouzic, Serge Benichou
Oct 16, 1999·Proceedings of the National Academy of Sciences of the United States of America·S A StewartI S Chen
Oct 24, 2000·Leukemia & Lymphoma·J KulkoskyR J Pomerantz
Jul 29, 2009·The Journal of Cell Biology·George B KyeiVojo Deretic
Sep 30, 2009·Expert Opinion on Drug Metabolism & Toxicology·David James Hooker, Catherine Louise Cherry
Sep 17, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Karin Lore, Marie Larsson
May 16, 2009·Journal of Applied Toxicology : JAT·Carla FanizzaDelia Cavallo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.